Next to determine whether the effect of Tollip on HCC development was dependent on PI3K/AKT signaling activation, the HCC cells transfected with Tollip-OE were treated with LY294002 (an inhibitor for PI3K/AKT pathway), which had been testified by western blot (Figure 5a). The gene discussed is TOLLIP; the disease is hepatocellular carcinoma.